🇺🇸 FDA
Pipeline program

Radiotherapy plus temozolomide

YZheng

Phase 2 small_molecule active

Quick answer

Radiotherapy plus temozolomide for Glioma (Any Grade) in the Brain is a Phase 2 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Glioma (Any Grade) in the Brain
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials